RT Journal Article
SR Electronic
T1 721 Ongoing phase 1 study of MP0317, a FAP-CD40 DARPin, shows a favorable safety profile and early evidence of tumor-localized CD40 activation in patients with advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A816
OP A816
DO 10.1136/jitc-2023-SITC2023.0721
VO 11
IS Suppl 1
A1 Gomez-Roca, Carlos
A1 Steeghs, Neeltje
A1 Gort, Eelke
A1 Winter, Hilde De
A1 Fernandez, Elena
A1 Stavropoulou, Vaia
A1 Stojcheva, Nina
A1 Baverel, Paul
A1 Krieg, Jennifer
A1 Ioannou, Kyriaki
A1 Florescu, Ana Maria
A1 Hoenig, Lea
A1 Baud-Berthier, Bruno
A1 Sanderson, Michael P
A1 Kirkin, Vladimir
A1 Goubier, Anne
A1 Legenne, Philippe
A1 Cassier, Philippe
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A816.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.